tirzepatide ozempic F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Switching between weight-loss medications -

no yes FDA does not regulate the safety, effectiveness, or quality of compounded drugs safety, effectiveness, or quality regulated by the FDA yes yes similar to Mounjaro more common side effects are digestive side effects, such as nausea or vomiting some compounded drugs may be less expensive, but insurance may not cover compounded drugs depends on insurance coverage Talk with your doctor about the risks and benefits of Mounjaro and compounded tirzepatide

Temporary dose reduction may be necessary for severe refractory cases, but most patients achieve adequate control through behavioral and H2 blocker intervention

Rodriguez et al., JAMA Internal Medicine 2024 Importantly, semaglutide is not a step down in terms of efficacy for every patient

Below is a general outline of how dosing may progress